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Abstract
Alcoholism is a devastating brain disorder that affects millions of people worldwide. The development of alcoholism is
caused by alcohol-induced maladaptive changes in neural circuits involved in emotions, motivation, and decision-making.
Because of its involvement in these processes, the amygdala is thought to be a key neural structure involved in alcohol
addiction. However, the molecular mechanisms that govern the development of alcoholism are incompletely understood.
We have previously shown that in a limited access choice paradigm, C57BL/6J mice progressively escalate their alcohol
intake and display important behavioral characteristic of alcohol addiction, in that they become insensitive to quinine-
induced adulteration of alcohol. This study used the limited access choice paradigm to study gene expression changes in
the amygdala during the escalation to high alcohol consumption in C57BL/6J mice. Microarray analysis revealed that
changes in gene expression occurred predominantly after one week, i.e. during the initial escalation of alcohol intake. One
gene that stood out from our analysis was the adapter protein 14-3-3f, which was up-regulated during the transition from
low to high alcohol intake. Independent qPCR analysis confirmed the up-regulation of amygdala 14-3-3f during the
escalation of alcohol intake. Subsequently, we found that local knockdown of 14-3-3f in the amygdala, using RNA
interference, dramatically augmented alcohol intake. In addition, knockdown of amygdala 14-3-3f promoted the
development of inflexible alcohol drinking, as apparent from insensitivity to quinine adulteration of alcohol. This study
identifies amygdala 14-3-3f as a novel key modulator that is engaged during escalation of alcohol use.
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Introduction
Alcoholism, characterized by a loss of control over alcohol
intake, is a disease that affects over 76 million people worldwide
[1]. Although recent years have seen progress in this regard,
treatment strategies for alcoholism are still limited in number and
efficacy [2–4], which underscores the pressing need to understand
the neural underpinnings of alcoholism.
The development of alcoholism is caused by alcohol-induced
maladaptive changes in neural circuits involved in emotions,
motivation, habit formation and decision making [5–11]. The
amygdala is a key structure in several of these processes. Within
the amygdala, integration of sensory information and attribution
of affective valence to primary rewards and associated cues takes
place. Connections of the amygdala with the nucleus accumbens,
ventral tegmental area and prefrontal cortex allow amygdaloid
mechanisms to influence various aspects of alcohol-motivated
behavior, while projections from the amygdala to hypothalamus
and brainstem contribute to arousal and stress that promote
alcohol intake [12–18].
Human alcoholics have reduced amygdala volumes [19] and
exposure of alcoholics to alcohol odor induces intense craving that
is associated with amygdala activation [20]. Consistent with its role
in processing negative emotional stimuli, the amygdala contributes
to alcohol consumption in alcohol-dependent animals that display
enhanced negative affect. Increased alcohol intake and enhanced
negative affect, apparent from decreased brain reward and
enhanced anxiety-like behavior, in alcohol-dependent animals is
associated with neurophysiological changes in the amygdala
including enhanced CRF and GABA release [21–23]. These
observations are consistent with the known involvement of the
amygdala in the generation and perception of positive and
negative emotions [17,24], as well as in the influence of
behaviorally meaningful environmental cues, such as drug-
associated conditioned stimuli, on behavior [13,16,17,25–27].
Recent evidence has implicated physiological changes in the
central nucleus of the amygdala (CeA) in alcohol intake. Thus,
escalation of alcohol intake and the development of alcohol
dependence has been shown to be paralleled by alterations in
neuropeptide expression and changes in GABAergic neurotrans-
mission [28,29] and to involve PKC signaling [30], but the
molecular mechanisms involved remain incompletely understood.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37999The aim of this study was to identify molecular mechanisms in
the amygdala that contribute to the escalation of alcohol intake,
which is an important stage in the development of drug addiction
[31]. During the development of alcoholism, casual alcohol use
escalates into excessive drinking, ultimately culminating in full-
blown alcohol addiction, characterized by loss of control over
alcohol intake. For this study we used a limited access choice
paradigm, in which C57BL/6J mice show rapid escalation of
alcohol consumption [32], which depends on processes within the
CeA [30]. Moreover, using this paradigm C57BL/6J mice display
alcohol use despite adverse consequences, an important behavioral
characteristic of alcoholism, in that they fail to reduce their alcohol
intake when an alcohol solution is adulterated with quinine and
consume an aversive, quinine-containing alcohol solution despite
the simultaneous availability of unadulterated alcohol [33]. Here,
we studied gene expression patterns in the CeA during the
escalation of alcohol intake in C57BL/6J mice, using microarray
analysis followed by qPCR. We subsequently used RNA interfer-
ence to pinpoint the involvement of 14-3-3f, a candidate gene that
stood out from our analysis, in alcohol intake. Together, these data
show that 14-3-3f signaling in the CeA controls the escalation of
alcohol intake in mice.
Materials and Methods
Animals
8–10 Weeks old male C57BL/6J mice, derived from Jackson
Labs (Bar Harbor, Maine, USA) and bred in our facility, were
group-housed with food and water ad libitum under controlled
conditions (2062uC and 50–70% humidity) and acclimatized to a
12-h light/dark cycle (7:00 AM lights off) at least 2 weeks prior to
testing. Experimental procedures were approved by the Animal
Ethics Committee of Utrecht University and conducted in
agreement with Dutch laws (Wet op de dierproeven, 1996) and
European regulations (Guideline 86/609/EEC).
Limited access alcohol consumption
Mice were trained to voluntarily consume alcohol using a
limited access choice paradigm [30,34,35]: they had access to one
drinking tube containing tap water and one containing alcohol
(10–15% v/v) in daily 2 hour sessions, starting 3 hours into the
dark cycle. Bottle positions were switched daily after 7 days to
avoid side-preference. Fluid volumes were measured and alcohol
intake, alcohol preference and total volume consumed were
calculated.
For microarray analysis, mice were randomly assigned to 3
experimental groups that consumed alcohol for 1, 2 or 4
consecutive weeks (N=14, 14 and 13), representing 3 stages of
the development of alcoholism: initial escalation of alcohol intake
(1 week), the stage where high alcohol intake is reached and
insensitivity to quinine adulteration emerges [33] and the stage of
stable high alcohol intake (4 weeks). A water control group (N=6)
was included and a group of naı ¨ve mice (N=21) served as a
reference sample. To ensure active engagement in the limited
access choice paradigm and to exclude animals consuming
extremely high or low amounts of alcohol, we applied the
following inclusion criteria.
(1) To ensure sufficient sampling of the fluids, total fluid intake should
be $12 ml/kg on day 6 [30,32].
(2) To ensure active engagement and motivation to consume alcohol,
preference for alcohol over water should be .50% by
day 6–8.
(3) To ensure analysis of escalation, alcohol intake should be #2 g/kg
by day 4 and $0.6 g/kg by day 6–8.
The final sample size after application of these criteria was
N=6.
For qPCR validation, a separate batch of mice consumed
alcohol for 1 week or 2 weeks (N=13); a total of 6 and 7 mice,
respectively, met the inclusion criteria. Naı ¨ve mice (N=7) and a
water group (N=6) were included as controls.
Tissue dissection
The mice were sacrificed by decapitation 10–11 hours after the
final limited access choice session. Blood alcohol analyses using an
NAD/ADH assay (Sigma, Germany) confirmed clearance of
alcohol from blood at this time: blood alcohol levels were low (6.5–
35 mg/dl) compared to levels of 97.7624.9 mg/dl immediately
after a drinking session [32]. Brains were dissected, snap frozen on
dry ice and stored at 280uC. Amygdala samples were obtained
using a 20G punch needle, aiming at the CeA [30,36] and were
immersed instantly in RNAlater (Sigma, Germany). Total RNA
was isolated from the amygdala using TRIzol (Invitrogen, NL),
DNAse treated (Ambion, TX, USA) and purified using the
RNeasy MinElute Cleanup kit (Qiagen N.V., NL). RNA integrity
was confirmed using the Bioanalyzer (Agilent Technologies Inc,
CA, USA).
RNA isolation and Hybridization
Two-color oligonucleotide microarray analysis was performed
as described [37]. RNA was amplified in a single round and
complementary DNA (cDNA) was synthesized with Superscript III
reverse transcriptase (Invitrogen) using a T7 oligo(dT)24VN
primer [38]. Complementary DNA was transcribed in vitro using
the T7Megascript kit (Ambion) in the presence of aminoallyl-UTP,
and copy ribonucleic acid (cRNA) quality was evaluated using the
Bioanalyzer. Cy3 or Cy5 fluorophores (Amersham Biosciences,
NL) were coupled to 1500 ng cRNA, and label incorporation was
monitored by spectrophotometry and hybridizations were set up
with 1000 ng of Cy3-labeled and 1000 ng of Cy5-labeled cRNA.
Each cRNA sample was labeled with Cy3 or Cy5 and was
hybridized in dye swap against a common reference pool sample
consisting of RNA from naı ¨ve mice; a total of 6 slides were
hybridized for each experimental group. The mouse Array-Ready
oligo set (version 3.0; Operon Biotechnologies GmbH, Germany)
was printed on Corning UltraGAPS slides as previously described
[37]. Slides were washed manually, scanned in the Agilent
G2565AA DNA Microarray Scanner (100% laser power and
30% photomultiplier tube) and quantified and background
corrected with IMAGENE (version 5.6.1; BioDiscovery, Inc.,
CA, USA) and Loess normalized per print-tip [39].
The microarray data were analyzed by ANOVA-modeling [40]
to identify genes that show differential expression from naı ¨ve
control mice. In a fixed effect analysis, sample, array and dye
effects were modeled. Sample-specific differences between groups
were then modeled and tested using permutations and family-wise
error correction. MIAMEcompliant descriptions of protocols,
experiment design, arrays, raw and normalized data have been
deposited in the public microarray database ArrayExpress (http://
www.ebi.ac.uk/arrayexpress/), all under the experiment accession
number E-TABM-956. In addition, the microarray data was
analyzed using the short time-series expression miner (STEM) with
integrated gene ontology (GO) database [41].
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Total RNA was isolated from the amygdala as described and
cDNA was synthesized from the RNA samples using oligo-dT
primers. qPCR analysis was performed using the LightCycler
(Roche, NL), the Fast Start DNA Master PLUS SYBRgreen I kit
(Roche) and primers listed in Table 1. After initial normalization
to the housekeeping gene beta-actin, gene expression was
calculated as the ratio to levels of naı ¨ve mice using the comparative
Ct method [42].
RNA interference
Two shRNAs were designed for mouse 14-3-3f (YWHAZ,
NCBI accession no. NM_011740): 1222 bp (GTGAAGAGTCG-
TACAAAGG) and 1854 bp (GAAGTTGTCTCTAGACAAG).
A non-coding sequence was used as a control (GCGTGTACG-
GACCTATTGG). The sequences were cloned into a LentiLox
3.7 vector (pLL3.7, http://www.sciencegateway.org/protocols/
lentivirus/pllmap.html).
Knockdown efficiencies were determined by transfection of
Neuro2A cells with the respective lentiviral vectors and semi-
quantitative 14-3-3f protein analysis by western blot 48 hours
after transfection. For each condition 5, 10, 15 and 20 mg protein
was loaded and 14-3-3f was visualized using goat anti-14-3-3f
antibody (SantaCruz, 1:5000), donkey anti-goat HRP (Jackson
ImmunoResearch, 1:25.000) and detection by enhanced chemilu-
minescence (Thermo Scientific). Knockdown efficiency was
determined by densitometry and comparative slope analysis as
described [30].
Lentivirus was produced by co-transfecting HEK293T cells
with the respective shRNA-pLL3.7 vector (22.5 mg), pMD2\VSV-
G (7.9 mg), pMDL\pRRE (15.6 mg) and pRSV-Rev (5.6 mg). Viral
titers were determined in Neuro2A cells and expressed as number
of infected GFP-positive cells per viral volume.
In vivo knockdown of 14-3-3f in the CeA and alcohol
intake
To establish in vivo knockdown of 14-3-3f, male C57BL/6J mice
were anaesthetized with ketamine (75 mg/kg i.p.) and medetomi-
dine (1 mg/kg i.p.) and placed in a stereotaxic frame (David Kopf
Instruments, CA, USA). The injectors (33G) were targeted at the
CeA using the coordinates: 20.90 mm posterior to bregma, +/2
3.0 mm lateral to midline and 24.6 mm ventral from bregma
[36]. Lentivirus (2 ml, 3610
7 iU/ml) was infused at a rate of
0.2 ml/min.
To determine knockdown efficiency in vivo, control lentivirus
was infused in one hemisphere and lentivirus expressing 1854 14-
3-3f shRNA was infused into the contralateral CeA. Three weeks
after infection, in situ hybridization for 14-3-3f and GFP was
performed using digoxigenin-labeled cRNA probes transcribed
from mouse 14-3-3f (1046 bp fragment) and eGFP (720 bp
fragment) cDNAs as described [43] and mRNA levels were
compared within animals (N=3).
For alcohol consumption experiments, control or 14-3-3f
shRNA expressing lentivirus was infused bilaterally into the
CeA. Alcohol consumption was determined in the limited access
choice paradigm as described (N=8–9) after 3 weeks post-surgery
recovery and adaptation to the reversed light-dark cycle (7:00 AM
lights off). Inflexible drinking behavior was assessed by adulterat-
ing alcohol (15% v/v) with graded quinine concentrations
(100 mM, 250 mM, 350 mM, 500 mM and 750 mM) on 5
consecutive days [33]. Alcohol intake and preference were
normalized to the group average over the last 3 days prior to
quinine modulation. After completion of the alcohol consumption,
intake of sweet (sucrose / saccharin) and bitter (quinine) solutions
was also determined in two-bottle choice tests.
Post-mortem immunohistochemistry for GFP was performed
using an anti-sheep antibody (1:5000, Biogenesis Ltd) to determine
the infection site.
Data Analysis
Consumption data were analyzed by one-way repeated measures
ANOVA with group as the between-subjects factor and time or
quinine concentration as the repeated measures within-subjects
factor. qPCR data were analyzed by one-way ANOVAs with group
as the between-subjects factor, followed by Tukey HSD multiple
comparisons. Post-hoc analysis was performed by two-tailed t-tests
where appropriate. Differences between pairs of means were
considered significant at alpha , 0.05. SPSS 15.0 was used for
data analysis.
Results
Gene expression during the escalation of alcohol intake
In order to trace molecular mechanisms engaged during the
escalation of alcohol intake, gene expression in the CeA was
studied by microarray analysis after 1 week, 2 weeks and 4 weeks
of daily alcohol consumption (Fig. 1A–B). Alcohol preference was
high from the first week of the experiment onwards (1 week
F(time)5,65=1.7, N.S.; 2 weeks F(time)7,70=0.97, N.S.; 4 weeks
F(time)10,50 =1.1, N.S.) while alcohol intake stabilized only after
two weeks of daily drinking. The experimental groups represent 3
stages of escalation to alcoholism-like behavior: the transition from
low to high alcohol intake (1 week; intake: F(time)5,75=16.8,
P,0.001), the stage when mice reach their highest levels of
alcohol intake and start to show inflexible and indifferent alcohol
intake (2 weeks; see Lesscher et al, 2010; intake: F(time)7,70=10.3,
P,0.001) and finally also the stage where high alcohol intake has
stabilized (4 weeks; intake: F(time)10,50=0.87, N.S.). Microarray
analysis revealed marked changes in gene expression as a result of
alcohol consumption, particularly during the early stages of
alcohol intake (P,0.01 from control mice, Fig. 1D and Fig. 1E–
F). After exclusion of those genes that showed differential
expression after water consumption compared to naı ¨ve mice,
267 genes in the CeA were found to be differentially regulated
after 1 week of alcohol consumption, i.e. during the transition
from low to high alcohol intake. Of these 267 genes, 211 were up-
regulated and 56 were down-regulated. By contrast, only 29 and
20 genes, respectively, were differentially regulated after 2 and
Table 1. Primer sequences for qPCR validation.
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are reached and signs of alcoholism-like behavior emerge, and
alcohol intake is stabilized. Regulated genes in all three
experimental groups are presented in Table 2.
Gene Ontology for those genes that were regulated specifically
during the first week of alcohol consumption identified significant
enrichment of genes involved in transport, ligand-gated ion
channel activity, synaptic transmission and cytoplasm (Penrichment
,0.01, Table 3). Based on effect size, significance and evidence for
involvement in processes that likely contribute to alcoholism, e.g.
synaptic plasticity, memory processing or addiction-related signal-
ing pathways, eight top candidate genes were selected for further
investigation. The top candidate genes that we identified include
genes which have previously been associated with alcoholism, such
as Gabrg2, Gabrb3 and Gria3 [44,45], but also genes that have
not been associated with alcoholism before. Those novel genes are
the adapter protein 14-3-3f, the G-protein associated sorting
protein Gprasp1, two genes involved in structural and functional
plasticity (Tmod2 and Ctnnd2) and Prkacb, which has been
postulated to affect cAMP-dependent gene expression. qPCR
analysis for the 8 top candidate genes in an independent batch of
mice confirmed significant up-regulation of Gria3, Gabrb3, 14-3-
3f and Prkacb in the CeA after alcohol consumption (Fig. 2).
Water consumption did not affect the expression of any of the
genes tested (not shown).
Amygdala 14-3-3f controls the development of
alcoholism
Of the genes that were consistently up-regulated during
escalation of alcohol intake, we found 14-3-3f to be of particular
interest. 14-3-3 Proteins are adapter proteins that have multiple
Figure 1. Alcohol intake and preference for C57BL/6J mice that consumed alcohol for 1, 2 or 4 weeks. A The mice show a progressive
increase in alcohol intake during the first two weeks of the experiment, stabilizing thereafter. B Preference for alcohol was high throughout the
experiment. C RNA for microarray analysis was isolated from 0.6 mm diameter punches (O) from serial sections through the CeA. D The majority of
the gene expression changes occurred after 1 week of alcohol consumption; the bar graph shows the total numbers of up- (black) and down-
regulated (grey) genes for each time-point while the Venn Diagram shows the total number of up- and down-regulated genes (marked by arrows) for
each time-point and overlap between the experimental groups. E–F Analysis of the microarray data using the Short Time Series Expression Miner
(STEM), revealed significant gene enrichment particularly during the early stages of escalation of alcohol intake (week 1 and/or week 2). When
considering all possible time profiles for gene expression after 1 wk, 2 wk and 4 wk of alcohol consumption, relative to data from naı ¨ve control mice
(exemplified by E), 6 time profiles showed significant gene enrichment: they represented more genes than expected based on chance (F). The
commonality between these 6 significant time profiles is that they all show an initial change in gene expression, normalizing thereafter to baseline
levels.
doi:10.1371/journal.pone.0037999.g001
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on gene expression changes in the amygdala of C57BL/6J mice.
Symbol Gene description p value EtOH/N
1 week alcohol consumption
*
Prkacb cAMP-dependent protein kinase, beta-catalytic subunit 0,0013 1,44
Ywhaz 14-3-3 protein zeta/delta 0,0001 1,43
Mapk10 Mitogen-activated protein kinase 10 0,0007 1,38
Gprasp1 G-protein coupled receptor-associated sorting protein 1 0,0034 1,36
Rasgrp1 RAS guanyl releasing protein 1 0,0037 1,35
Rdm1 RAD52 motif-containing protein 1 0,0024 1,34
Camk2a Calcium/calmodulin-dependent protein kinase type II alpha chain 0,0002 1,32
Eif4a2 Eukaryotic initiation factor 4A-II 0,0003 1,31
Trim37 Tripartite motif-containing protein 37 0,0098 1,30
Pdia3 Protein disulfide-isomerase A3 precursor 0,0005 1,30
Slc22a17 solute carrier family 22 (organic cation transporter), member 17 0,0055 1,30
Atp6ap1 Vacuolar ATP synthase subunit S1 precursor 0,0002 1,29
Zfp758 zinc finger protein 758 0,0001 1,28
Arf1 ADP-ribosylation factor 1 0,0034 1,28
Rtn4 Reticulon-4 (Neurite outgrowth inhibitor) 0,0003 1,28
Lgi1 Leucine-rich glioma-inactivated protein 1 precursor 0,0094 1,27
Trim23 GTP-binding protein ARD-1 0,0018 1,26
Cdk5rap2 CDK5 regulatory subunit-associated protein 2 0,0000 1,26
Fbxl3 F-box/LRR-repeat protein 3 0,0079 1,26
Cd47 Leukocyte surface antigen CD47 precursor 0,0038 1,26
Pcmtd1 Protein-L-isoaspartate O-methyltransferase domain-cont protein1 0,0036 1,26
Arhgef9 Rho guanine nucleotide exchange factor 9 0,0016 1,26
Actg2 Actin, gamma-enteric smooth muscle 0,0000 1,26
Ptk2b Protein tyrosine kinase 2 beta 0,0022 1,25
Homer1 Homer protein homolog 1 0,0003 1,25
Lrp11 Low-density lipoprotein receptor-related protein 11 precursor 0,0008 1,25
Dnajc5 DnaJ homolog subfamily C member 5 0,0016 1,25
Ybx1 Nuclease sensitive element-binding protein 1 0,0024 1,24
Gls glutaminase isoform 1 0,0079 1,24
Arf1 ADP-ribosylation factor 1 0,0038 1,24
Eif4h Eukaryotic translation initiation factor 4H 0,0045 1,23
Azin1 Antizyme inhibitor 1 (AZI) 0,0016 1,23
Syn2 Synapsin-2 0,0002 1,23
Gapdh Glyceraldehyde-3-phosphate dehydrogenase 0,0037 1,23
Lrrc58 Leucine-rich repeat-containing protein 58 0,0011 1,23
Tmod2 Tropomodulin-2 0,0023 1,23
Slc17a7 solute carrier family 17 0,0001 1,23
Wsb2 WD repeat and SOCS box-containing protein 2 0,0033 1,22
Gria3 Glutamate receptor 3 precursor 0,0001 1,22
Hnrpk Heterogeneous nuclear ribonucleoprotein K 0,0007 1,22
Ube2d3 Ubiquitin-conjugating enzyme E2 D3 0,0001 1,22
Cabp5 Calcium-binding protein 5 0,0000 1,22
Sec23a Protein transport protein 0,0001 1,22
Ddx3x ATP-dependent RNA helicase 0,0020 1,22
Gapdh Glyceraldehyde-3-phosphate dehydrogenase 0,0001 1,22
Fbxl16 F-box/LRR-repeat protein 16 0,0010 1,22
Usp31 MKIAA1203 protein 0,0026 1,22
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Symbol Gene description p value EtOH/N
Pja2 E3 ubiquitin-protein ligase Praja2 0,0000 1,22
Srp54a Signal recognition particle 54 kDa protein 0,0010 1,22
Igf1r Insulin-like growth factor 1 receptor precursor 0,0000 1,21
Ube2i SUMO-conjugating enzyme UBC9 0,0026 1,21
Arl8b ADP-ribosylation factor-like protein 8B 0,0001 1,21
Gabrb3 Gamma-aminobutyric acid receptor subunit beta-3 precursor 0,0002 1,21
Lpgat1 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 0,0002 1,21
Mrfap1 MORF4 family-associated protein 1 0,0073 1,21
Gabrg2 Gamma-aminobutyric acid receptor subunit gamma-2 precursor 0,0000 1,21
Txndc13 Thioredoxin domain-containing protein 13 precursor 0,0003 1,21
Rab18 Ras-related protein Rab-18 0,0024 1,21
Kcnma1 Calcium-activated potassium channel subunit alpha-1 0,0001 1,21
Spag9 C-jun-amino-terminal kinase-interacting protein 4 0,0010 1,21
Peg3 Paternally-expressed gene 3 protein (ASF-1) 0,0002 1,21
Pten Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase 0,0019 1,21
Synj1 Synaptojanin-1 0,0055 1,21
Slc4a10 Sodium-driven chloride bicarbonate exchanger 0,0016 1,21
Kpna3 Importin subunit alpha-3 0,0015 1,20
Abr active BCR-related isoform 2 0,0052 1,20
Ccdc132 Coiled-coil domain-containing protein 132 0,0099 1,20
Ap2a2 AP-2 complex subunit alpha-2 0,0002 1,20
Ppp2ca Serine/threonine-protein phosphatase 2A catalytic subunit alpha 0,0014 1,20
Cap2 Adenylyl cyclase-associated protein 2 0,0002 1,20
Psap Sulfated glycoprotein 1 precursor (SGP-1) 0,0021 1,20
Elmo2 Engulfment and cell motility protein 2 0,0080 1,20
Kcnip2 Kv channel-interacting protein 2 0,0043 1,20
Atp5k ATP synthase subunit e, mitochondrial 0,0001 0,81
Mt2 Metallothionein-2 0,0034 0,81
Tsx Testis-specific protein 0,0016 0,80
Olfr779 Olfactory receptor Olfr779 0,0002 0,79
Olfr806 olfactory receptor 806 0,0085 0,77
2 weeks alcohol consumption
Vsnl1 Visinin-like protein 1 0,0001 1,33
Tmem130 Transmembrane protein 130 precursor 0,0005 1,27
Pdia3 Protein disulfide-isomerase A3 precursor 0,0016 1,26
Ipo7 Importin-7 0,0001 1,24
Camk2d Calcium/calmodulin-dependent protein kinase type II delta chain 0,0005 1,18
Ranbp6 Ran-binding protein 6 0,0016 1,18
Atp6ap1 Vacuolar ATP synthase subunit S1 precursor 0,0081 1,18
Ppap2b Lipid phosphate phosphohydrolase 3 0,0083 1,17
Ptprz1 protein tyrosine phosphatase, receptor type Z, polypeptide 1 0,0004 1,17
Zbtb2 zinc finger and BTB domain containing 2 0,0005 1,16
Prkar2b cAMP-dependent protein kinase type II-beta regulatory subunit 0,0051 1,16
Zdhhc2 Palmitoyltransferase ZDHHC2 0,0072 1,16
Rab6 Ras-related protein Rab-6A 0,0099 1,16
Slc6a1 Sodium- and chloride-dependent GABA transporter 1 0,0016 1,16
Arhgap5 Rho GTPase activating protein 5 0,0029 1,16
Gls glutaminase isoform 1 0,0028 1,15
Gabrg1 Gamma-aminobutyric acid receptor subunit gamma-1 precursor 0,0049 1,15
Amygdala 14-3-3f Modulates Alcohol Intake
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37999and diverse binding partners [46,47]. These include transcription
factors and signaling molecules such as PKCs [48] and ionotropic
glutamate receptors [49] that have previously been implicated in
alcoholism [30,44,50-53]. Therefore, 14-3-3 proteins are well
positioned to integrate signaling inputs and influence alcohol
addiction. Indeed, previous studies reported gene and protein
expression changes for 14-3-3f in the nucleus accumbens and
amygdala after prolonged alcohol use [54,55] and a recent study
has shown reduced 14-3-3f in brain tissue of human alcoholics
[56]. Because we found that amygdala 14-3-3f levels were up-
regulated during the escalation of alcohol intake, we investigated
whether amygdala 14-3-3f contributes to the escalation of alcohol
intake in mice. For this purpose, lentiviral vectors expressing 14-3-
3f specific shRNA sequences (1222 and 1854 bp, Fig. 3A) were
generated to reduce the expression of 14-3-3f in vivo. As a control,
a shRNA sequence that did not recognize any known mammalian
gene in a BLAST search was used. Of the two shRNA constructs
tested, the 1854 construct was most effective in knocking down 14-
3-3f in vitro (Fig. 3B). Densitometry and slope analysis revealed
lower 14-3-3f protein levels in Neuro2A cells that were transfected
with both 14-3-3f shRNA constructs. Knockdown efficiency,
calculated from the ratio of the slopes for 14-3-3f shRNA over
those for untreated cells, was greater for the 1854 construct (71%)
as compared to the 1222 shRNA construct (38%). In contrast, the
scrambled construct did not affect 14-3-3f protein expression (2.5–
3.7% change from untreated cells). In situ hybridization after
unilateral infusion of the 1854 14-3-3f shRNA expressing
lentivirus in the CeA and infection with the scrambled shRNA
expressing lentivirus in the contralateral CeA confirmed effective
knockdown of 14-3-3f in vivo in the CeA using this same 14-3-3f
shRNA construct (1854 bp, Fig. 3C). Comparison of adjacent
sections stained for GFP, to localize the infection site, with sections
stained for 14-3-3f revealed that 14-3-3f mRNA was completely
absent in the CeA that was infected with the 1854 14-3-3f shRNA
expressing lentivirus while 14-3-3f was expressed in the contra-
lateral CeA that was infected with the scrambled shRNA
expressing lentivirus.
The effects of 14-3-3f knockdown on escalation of alcohol
intake were determined by bilaterally infusing either the 1854 14-
3-3f or the control lentivirus into the CeA and allowing the mice
to consume alcohol in the limited access choice paradigm. The
mice with CeA knockdown of 14-3-3f using the 1854 14-3-3f
shRNA construct showed increased alcohol intake (45-53%
increase from control in weeks 3 and 4; Fig. 4A, 10% v/v; rep.
measures ANOVA: Fgroup(1,12)=1.3, N.S., Ftime x group(18,216)=2.0,
P,0.05). Mice that were infected with the less effective 1222 14-3-
3f shRNA expressing lentivirus showed a less prominent but
significant increase in alcohol intake (23–22% increase from
control in weeks 3 and 4; Fig. 4B, 10% v/v; rep. measures
ANOVA: Ftime x group(18,216)=2.6, P,0.01), demonstrating a gene-
dosage effect of amygdala 14-3-3f on alcohol intake. We next
confirmed the involvement of amygdala 14-3-3f in alcohol
Table 2. Cont.
Symbol Gene description p value EtOH/N
Dpp6 Dipeptidyl aminopeptidase-like protein 6 0,0022 1,15
Calcr Calcitonin receptor precursor 0,0069 1,15
Olfr779 Olfactory receptor 0,0010 0,85
Ap4e1 AP-4 complex subunit epsilon-1 0,0003 0,83
Tesc Tescalcin 0,0070 0,83
Rpl27a ribosomal protein L27a 0,0007 0,83
Itpka Inositol-trisphosphate 3-kinase A 0,0099 0,82
Cck Cholecystokinins precursor 0,0072 0,81
4 weeks alcohol consumption
Pum2 Pumilio homolog 2 0,0061 1,24
Igf1r Insulin-like growth factor 1 receptor precursor 0,0030 1,21
Pisd Phosphatidylserine decarboxylase proenzyme 0,0021 1,20
Pkia cAMP-dependent protein kinase inhibitor alpha 0,0033 1,19
Ptprz1 protein tyrosine phosphatase, receptor type Z, polypeptide 1 0,0021 1,19
Prepl Prolyl endopeptidase-like 0,0039 1,18
Peg3 Paternally-expressed gene 3 protein (ASF-1) 0,0058 1,17
Kpna1 Importin subunit alpha-1 0,0003 1,17
Prkacb cAMP-dependent protein kinase, beta-catalytic subunit 0,0015 1,17
Atp6ap1 Vacuolar ATP synthase subunit S1 precursor 0,0030 1,17
Homer1 Homer protein homolog 1 0,0032 1,16
Ncdn neurochondrin 0,0032 1,16
Dnm1 Dynamin-1 0,0085 1,16
Rasgrp1 RAS guanyl releasing protein 1 0,0003 1,16
Tmem40 Transmembrane protein 40 0,0059 0.84
*for the 1 week group only those genes are shown that display a change in expression of at least +/220% from naı ¨ve controls. EtOH/N = fold change of the EtOH
group (1 wk, 2 wk or 4 wk) to naı ¨ve controls. Hypothetical genes were excluded from this list.
doi:10.1371/journal.pone.0037999.t002
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concentration (15% v/v). In agreement with our initial exper-
iment, CeA 14-3-3f knockdown using the 1854 shRNA increased
intake of the 15% alcohol solution (63–73% increase from control
in weeks 1–3; Fig. 4C; rep. measures ANOVA: Fgroup(1,11)=5.1,
P,0.05, Ftime x group(13,143)=1.0, N.S.). Furthermore, to evaluate
the relevance of our findings for alcoholism-like behavior, we next
determined the effects of amygdala 14-3-3f knockdown on the
development of inflexible alcohol drinking [33]. For this purpose,
the alcohol solution was adulterated with graded concentrations of
the bitter substance quinine. The mice with CeA 14-3-3f
knockdown using the 1854 shRNA showed a persistent high
preference for the quinine-adulterated alcohol solution, indicative
of inflexible alcohol drinking (Fig. 4D;F quinine x group(5,50)=2.37,
P=0.053).
Finally, we also determined specificity of these findings for
alcohol and potential confounding effects of 14-3-3f knockdown
on taste sensitivity. Mice treated with the 14-3-3f 1854 shRNA
showed equal intake of the caloric sweet tastant sucrose (Fig. 5A;
Fgroup(1,11)=0.002, N.S.; Fsucrose x group(1,11)=1.04, N.S.) and the
non-caloric sweet tastant saccharin (Fig. 5B;F group(1,11)=2.5, N.S.;
Fsaccharin x group(1,11)=1.6, N.S.) as compared to control mice. The
groups also showed similar preference for these sweet solutions
(not shown). Mice with 14-3-3f knockdown also did not differ from
control mice in aversion for bitter quinine solutions (Fig. 5C;
Fgroup(1,11)=0.001, N.S.; Fquinine x group(1,11)=0.21, N.S.). Taken
together, the increase in alcohol intake in mice with CeA 14-3-3f
knockdown does not generalize to natural rewards and can not be
explained by altered taste sensitivity.
Bilateral infection of the CeA was confirmed by post-mortem
immunohistochemistry for GFP with the main infection site
located between 20.9 and 21.5 mm from bregma (Figure 4E)
[36]. Mice that showed unilateral infection were excluded from
further analysis; one mouse was excluded after histology revealed
hydrocephalus. There was occasional infection of the basolateral
nucleus of the amygdala and in the caudate putamen along the
injection tract.
Discussion
The development of alcoholism is a progressive process that
invariably starts with casual, social drinking, which escalates to
heavy drinking, problem drinking and ultimately alcohol addic-
tion. Consistent with its role in processing negative emotional
stimuli, the amygdala contributes to alcohol consumption in
human alcoholics and alcohol-dependent animals that display
enhanced negative affect [19–22]. However, the amygdala is also
important for perception of positive emotions [17] and it may
therefore also be involved in the reinforcing properties of alcohol
[57] and in escalation of alcohol intake in non-dependent animals
[30]. Here, we combined gene expression analysis, RNA
interference and a murine model for escalation of voluntary
alcohol intake to identify amygdala 14-3-3f as a novel key
modulator in the development of high alcohol intake.
Amygdala 14-3-3f and escalation of alcohol intake
In the limited access choice paradigm, C57BL/6J mice show a
rapid increase in alcohol intake in 7–10 days time. This rapid
acquisition of alcohol consumption is likely driven by the positive
subjective properties of alcohol. After two weeks of daily alcohol
consumption, the mice reach their highest levels of alcohol intake
and by that time, C57BL6/J mice also display inflexible alcohol
intake in that they are insensitive to quinine adulteration of the
alcohol solution when this is the sole source of alcohol [33]. In
subsequent weeks, C57BL/6J mice maintain high levels of alcohol
intake and develop indifferent alcohol drinking, indicated by
persistent intake from aversive, quinine-adulterated alcohol despite
the availability of non-adulterated alcohol [33]. Although the level
of alcohol exposure achieved in our rodent model may not be
sufficient to induce a genuine state of alcohol addiction, the
inflexible and indifferent alcohol drinking patterns displayed by
our mice show remarkable similarities to compulsive alcohol
drinking in human alcoholics [5860]. The limited access choice
paradigm therefore models important aspects of alcoholism-like
behavior.
Figure 2. qPCR data for mice that consumed alcohol for 1 week or 2 weeks. qPCR confirmed significant up-regulation of 4 out of 8
candidate genes when compared to naı ¨ve control mice: Gria3, 14-3-3 zeta, Gabrb3 and Prkacb. *P , 0.05, **P , 0.01 from naı ¨ve mice by Tukey HSD
multiple comparisons.
doi:10.1371/journal.pone.0037999.g002
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levels at three stages of the development of alcoholism-like
behavior: initial escalation of alcohol intake (1 week), the stage
where high alcohol intake is reached and signs of alcoholism-like
behavior emerge (2 weeks) and the stage of stable high alcohol
intake (4 weeks). Our analysis revealed that gene expression
changes in the amygdala occur predominantly during the initial
rapid escalation of alcohol intake (1 week). These data suggest that
the amygdala contributes to the positive subjective properties of
alcohol, which is consistent with the known involvement of the
amygdala in the generation and perception of stimuli with positive
emotional valence [16–18].
One of the genes that stood out from our analysis of alcohol-
regulated amygdala genes is 14-3-3f. Up-regulation of this gene
during initial escalation of alcohol intake was confirmed by qPCR
analysis in an independent batch of mice. Moreover, using RNA
interference we demonstrate functional involvement of amygdala
14-3-3f in the development of high alcohol intake and alcoholism-
like behavior. Local knockdown of 14-3-3f in the amygdala lead to
increased alcohol intake and a greater propensity to develop
inflexible alcohol intake. Together with the observed up-regulation
of 14-3-3f in the amygdala, these findings suggest that 14-3-3f
may serve to restrict alcohol intake.
The observed increase in alcohol intake after 14-3-3f knock-
down in the amygdala was behaviorally specific for alcohol, as we
did not observe alterations in preference for natural rewards, i.e.
sucrose and saccharin or in sensitivity to the aversive taste of
quinine. The enhanced alcohol intake after amygdala 14-3-3f
knockdown, together with the up-regulation of amygdala 14-3-3f
expression during the initial increase in alcohol intake suggests that
the rewarding properties of alcohol are increased in the absence of
14-3-3f. This implies that 14-3-3f may be a protective factor
against the development of alcoholism; up-regulation of 14-3-3f
would be required to demonstrate this role. The augmentation of
alcohol intake after amygdala 14-3-3f knockdown may also reflect
impaired behavioral control. In fact, the increase in inflexible
alcohol intake that we found is indicative of loss of control over
alcohol intake. However, it is also possible that mice with
amygdala 14-3-3f depletions consume more alcohol and as a
consequence develop inflexible alcohol intake more rapidly than
control mice.
Table 3. Gene Enrichment analysis in STEM.
Profile 45 Profile 47
Transport Ion transport
Ligand-gated ion









Gabra1 Gabra1 Gabra1 Itch
Gabrb3 Gabrb3 Gabrb3 Kif5A
Gabrg2 Gabrg2 Gabrg2 Gabrg2 Mgea5
Gopc Mrfap1
Gria1 Gria1 Gria1 Pdia3











Trim9 Trim9 14-3-3 g 14-3-3 g
Tsg101 14-3-3 h 14-3-3 h
14-3-3f
Gene Ontology analysis for the significant time profiles 45 and 47 in STEM revealed significant enrichment of genes involved in transport, ion transport, ligand-gated ion
channel activity, synaptic transmission, cytoplasm and protein transport. Highlighted are the selected 8 top candidate genes.
doi:10.1371/journal.pone.0037999.t003
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amygdala 14-3-3f in the escalation of alcohol intake: 14-3-3f
levels in the amygdala are enhanced and 14-3-3f knockdown
causes profound increases in alcohol intake in mice. Alcohol has
previously been shown to alter 14-3-3f levels, although in contrast
to our current findings only after extended alcohol exposure. For
example, prolonged alcohol use in rats and in alcohol dependent
mice induced increased 14-3-3f gene and protein expression in
nucleus accumbens and amygdala [54,55]. Moreover, a recent
study showed reduced 14-3-3f in the motor cortex of human
alcoholics, i.e. after extended alcohol abuse [56]. The apparent
contrast in the directional changes in expression of 14-3-3f may
reflect brain region dependency of 14-3-3f regulation by alcohol:
while 14-3-3f is consistently up-regulated by alcohol use in limbic
brain regions, the same gene may be down-regulated in cortical
regions. Although gene and protein expression changes may not
necessarily cause behavioral changes, these studies suggest
involvement of 14-3-3f in alcohol intake after prolonged alcohol
use. In conclusion, 14-3-3f pathways in the amygdala constitute
important mechanisms that are engaged during the descent of
casual alcohol intake into alcoholism-like behavior.
Biological function of 14-3-3f in relation to alcohol
consumption
14-3-3 proteins are adapter proteins, that have multiple and
diverse binding partners [46,47]. Upon binding, they can regulate
the activity or subcellular localization of other proteins and thereby
influencemultiplecellular processesincluding signaltransduction or
the cell cycle. 14-3-3 Proteins are most widely studied for their
involvement in cancer [47,61,62], but they have also been
associated with neurological diseases such as Parkinson’s disease
[63–65]. The binding partners of 14-3-3 proteins are diverse and
include transcription factors and signaling molecules. The molec-
ular mechanisms through which 14-3-3f influences alcohol
consumption are currently unknown. However, several binding
partners of 14-3-3 proteins have been implicated in alcoholism and
may contribute to 14-3-3 modulation of alcohol intake.
For example, 14-3-3f is known to interact with protein kinase C
isoforms (PKCs) including PKCe [48]. In fact, 14-3-3 was first
identified as aPKCinhibitor[66],althoughlaterreportsshowed that
14-3-3 may enhance PKC activity [48,67]. PKCs, including PKCd
and PKCe, are critically involved in alcohol sensitivity [52,53,68]. In
fact, amygdala PKCe is important for alcohol intake [30].
Interactions of 14-3-3f with PKCs may contribute to these effects.
14-3-3 proteins may also affect GABAergic neurotransmission.
Interactions of GABA-B receptor subunits with 14-3-3 proteins
were reported [69]. Further, 14-3-3 can affect the phosphorylation
of GABA-A receptor subunits [70] and GABA, in turn, can regulate
14-3-3 proteins [71]. Multiple studies have shown an association of
alcohol dependence to genes encoding GABA-A receptor subunits
alpha1 [45,72-76] and alcohol is known to regulate GABA-A
receptor subunits both in vitro and in vivo [77–81], possibly through
14-3-3f interactions with GABA-A receptors.
Interactions of 14-3-3 proteins with ionotropic glutamate
receptors [49] are another candidate mechanism through which
14-3-3 proteins may affect alcoholism. AMPA receptors have been
associated with alcoholism and alcohol intake in animal models
[44,50,51]. 14-3-3f may modulate alcohol consumption by
interacting with and affecting the activity of glutamate receptors.
Our microarray analysis revealed that, in addition to 14-3-3f,
the GABA-A b3 subunit (Gabrb3) and the AMPA receptor a3
subunit (GRIA3) were also up-regulated in the amygdala during
initial escalation of alcohol intake, suggesting that GABA-A and
AMPA receptors in the amygdala are also involved in escalation of
alcohol intake, possibly through interactions with 14-3-3f. Clearly,
the elucidation of the molecular mechanisms and binding partners
involved in 14-3-3f control over alcohol intake, both during
initiation and maintenance of alcohol use, should be addressed in
future research. In fact, the recent development of drugs that
Figure 3. Design and validation of 14-3-3f shRNA constructs. A 14-3-3f specific shRNA sequences (1222 and 1854 bp) were cloned into
pLentiLox3.7 vectors and B western blot analysis revealed that both constructs effectively reduced 14-3-3f protein levels in Neuro2A cells, the 1854
construct being most effective in vitro. C In situ hybridization confirmed effective knockdown of 14-3-3f in the CeA after infection with the 1854
shRNA expressing lentivirus. The top panels show 14-3-3f expression in the CeA after infection with the control or the 1854 shRNA expressing
lentivirus. The bottom panels show GFP mRNA and therefore the infection site in adjacent sections. 14-3-3f mRNA is completely absent in the area
that is infected with the 1854 shRNA expressing lentivirus.
doi:10.1371/journal.pone.0037999.g003
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e37999Figure 4. Effects of local knockdown of 14-3-3f in the CeA on alcohol consumption. A Local knockdown of 14-3-3f in the CeA using the
1854 shRNA increased intake of a 10% alcohol solution (v/v). B Infection with the less effective 1222 shRNA also increased alcohol intake of a 10%
alcohol solution (v/v), but less prominently so than the 1854 14-3-3f shRNA. C In a separate batch of mice, local knockdown of 14-3-3f in the CeA
using the 1854 shRNA increased alcohol intake of a 15% alcohol solution (v/v) and D local knockdown of 14-3-3f in the CeA using the 1854 shRNA
caused persistent preference for the alcohol solution despite adulteration with the bitter tastant quinine. In E the sites of viral infection in the brain
are summarized. The black ellipses show the core of the infection site that was consistently targeted across all animals. The areas marked in grey
represent less frequent infected sites that include the anterior amygdala, the basolateral amygdala and part of the caudate putamen, along the
injection tract.N Control mice; O 14-3-3f-specific shRNA treated mice. * P,0.05 from controls; # P,0.05, ## P,0.01 from 0 mM quinine for mice
treated with control lentivirus; $ P ,0.05 from 0 mM quinine for mice treated with the 1854 14-3-3f shRNA expressing lentivirus by t-test.
doi:10.1371/journal.pone.0037999.g004
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underscores the need to identify the 14-3-3f-protein complex that
governs the escalation of alcohol intake.
Conclusion
This study identifies amygdala 14-3-3f as a novel key modulator
of alcohol intake. Interactions of 14-3-3f with signaling proteins
such as PKCe [48] or neurotransmitter receptors [49] may
contribute to these effects. The recent development of 14-3-3
complex specific drugs provides exciting opportunities to develop
innovative treatment strategies for alcoholism.
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